Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sole U.S. Heparin Supplier Takes Steps To Guarantee Safety

This article was originally published in PharmAsia News

Executive Summary

U.S. drug maker APP Pharmaceuticals, now the only U.S. supplier of heparin, says it has taken several steps to ensure the safety of the blood-thinner relied on during open-heart surgery. Baxter International stopped being APP's heparin competitor after its Chinese-made heparin was recalled in the wake of 81 deaths and hundreds of adverse events last year. APP makes its heparin in U.S. and Puerto Rican plants. The company said it would use enhanced labeling, unit-of-use barcodes and other methods to ensure safety. The supply of heparin in the United States only recently returned to normal. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts